AI assisted drug design

AI assisted drug design is achieved through the integration of high-throughput pharmacokinetic simulations and drug molecule property predictions, as well as advanced evolutionary algorithms and massive amounts of biological data, to automate the drug design process. This includes various stages such as target discovery and confirmation in drug design, discovery and optimization of drug lead compounds, drug pharmacokinetics, and toxicity evaluation. AI assisted drug design is the trend for future innovative drug development, changing the traditional drug development process that is time-consuming, costly, and has a low success rate, and will strongly promote breakthroughs and innovation in new drug development.

The unit is designed for unsupervised public use: controls are recessed or shielded, moving parts are enclosed, and the interface is operable by a child of about six with no instruction. Where a screen is used, the language can be switched without changing the hardware, and the content can be replaced on site.

Drug development is a lengthy systematic engineering process that requires stages such as target identification and validation, lead discovery, lead optimization, preclinical research, clinical trials, and marketing. Recently, drug development has been in a state of high investment and low output, requiring new technologies to bring progress in drug development. It is worth considering how artificial intelligence and big data can play a role in today's drug development. The data-driven AI model can avoid the drawbacks of wasting manpower and resources in previous experimental trial and error models, making drug development more precise, personalized, information-based, and intelligent. AI technology has been involved in the development of new drugs for decades and has achieved significant success. AI helps find drug targets, perform virtual screening, optimize structures, and improve the efficiency and quality of exploring pharmaceuticals.